Civeo Corporation
NYSE:CVEOSpecialty Business Services
+$0.53 today
- Market cap
- $355.18M
- Beta
- 0.72
- P/E (TTM)
- -26.7
- EPS (TTM)
- -$1.26
Volume 0.09M
Average 0.07M
CVEO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Civeo CorporationNYSE: CVEO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CVEO compares with its peers on the latest reported figures
- CVEO's LTM Mar 2026 research & development of $0 is the 4th highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CVEO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $165.5M | +68.0% | +73.8% | — | |
| LTM Mar 2026 | $36.71M | +16.0% | +18.4% | 57.8% | |
| LTM Mar 2026 | $950K | -11.5% | -19.8% | 0.1% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
BNCCEA Industries Inc. Common Stock | LTM Apr 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CVEO) | $0 | +2.2% | +18.4% | 0.0% | |
Competitors are the stored peer set for CVEO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 594.46M | 697.05M | 700.81M | 682.12M | 638.85M |
| Cost of Revenue | 436.46M | 517.06M | 530.29M | 532.67M | 487.76M |
| Gross Profit | 158M | 179.99M | 170.52M | 149.46M | 151.09M |
| Gross Margin | 26.6% | 25.8% | 24.3% | 21.9% | 23.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.6M | 69.96M | 72.61M | 73.35M | 75.34M |
| Operating Expenses | 151.95M | 162.97M | 131.03M | 148.12M | 146.97M |
| Depreciation & Amortization | 83.1M | 87.21M | 75.14M | 68.04M | 72.62M |
| EBITDA | 101.94M | 109.95M | 128.68M | 70.07M | 77.58M |
| EBITDA Margin | 17.1% | 15.8% | 18.4% | 10.3% | 12.1% |
| Operating Income | 6.05M | 17.02M | 39.49M | 1.33M | 4.12M |
| Operating Margin | 1.0% | 2.4% | 5.6% | 0.2% | 0.6% |
| Interest Income | 2K | 39K | 172K | 187K | 164K |
| Interest Expense | 12.96M | 11.47M | 13.18M | 7.97M | 11.42M |
| Other Income / Expenses | (179K) | (6.29M) | 876K | (7.27M) | (10.57M) |
| Income Before Tax | 5.87M | 10.73M | 40.36M | (5.94M) | (6.46M) |
| Pre-Tax Margin | 1.0% | 1.5% | 5.8% | -0.9% | -1.0% |
| Income Tax Expense | 3.38M | 4.4M | 10.63M | 12.49M | 13.62M |
| Net Income | 1.35M | 4M | 30.16M | (17.07M) | (20.07M) |
| Net Margin | 0.2% | 0.6% | 4.3% | -2.5% | -3.1% |
| EPS (Basic) | (0.04) | (0.21) | 2.02 | (1.19) | (1.59) |
| EPS (Diluted) | (0.04) | (0.21) | 2.01 | (1.19) | (1.59) |
| Weighted Avg Shares | 14.23M | 14M | 14.91M | 14.29M | 12.65M |
| Weighted Avg Shares (Diluted) | 14.23M | 14M | 15.01M | 14.29M | 12.65M |
Civeo Corporation
NYSE:CVEO
Intrinsic Alpha fair value
Locked
Current Price
$34.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.